Inclusion criteria~* Age between 50 and 80 years~* National Institute on Aging/Alzheimer's Association core
clinical criteria for probable Alzheimer's disease (AD) dementia or mild cognitive impairment (prodromal AD)~*
Evidence of the AD pathological process, by a positive amyloid assessment either on cerebrospinal fluid AÎ²1-42
OR amyloid positron emission tomography (PET) scan. Historical amyloid PET scans may be accepted in some
cases~* Mild AD symptomatology, as defined by a screening Mini-Mental State Examination score of ≥ 20 points
and Clinical Dementia Rating (CDR) -Global Score of 0.5 or 1~* Abnormal memory function at screening~*
Availability of a person with sufficient contact with the participant to be able to provide accurate
information on the participant's cognitive and functional ability~
